We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 458 results
  1. Idiopathic CD4 Lymphopenia

    Idiopathic CD4 lymphopenia is a rare disorder of unknown etiology. It has a broad array of presentations, ranging from asymptomatic individuals to...
    Yuliya Afinogenova, Joel P. Brooks in Primary and Secondary Immunodeficiency
    Chapter 2021
  2. Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns

    Newborn screening (NBS) for severe inborn errors of immunity (IEI), affecting T lymphocytes, and implementing measurements of T cell receptor...

    Andrey V. Marakhonov, Irina Yu. Efimova, ... Sergey I. Kutsev in Journal of Clinical Immunology
    Article 05 April 2024
  3. Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies

    Idiopathic inflammatory myopathies (IIM) are a group of myopathies that present with muscle weakness and multiple extra-muscular manifestations, in...

    Zhou Pan, Mengdi Li, ... Yusheng Zhang in Inflammation
    Article 16 May 2024
  4. Characterization of Infants with Idiopathic Transient and Persistent T Cell Lymphopenia Identified by Newborn Screening—a Single-Center Experience in New York State

    Purpose

    Newborn screening (NBS) quantifies T cell receptor excision circles (TREC) and identifies infants with T cell lymphopenia (TCL). This study...

    Artemio M. Jongco III, Robert Sporter, ... Vincent R. Bonagura in Journal of Clinical Immunology
    Article 07 January 2021
  5. When Screening for Severe Combined Immunodeficiency (SCID) with T Cell Receptor Excision Circles Is Not SCID: a Case-Based Review

    Newborn screening efforts focusing on the quantification of T cell receptor excision circles (TRECs), as a biomarker for abnormal thymic production...

    David Buchbinder, Jolan E. Walter, ... Cathleen A. Collins in Journal of Clinical Immunology
    Article 07 January 2021
  6. Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies

    Chimeric antigen receptor (CAR)-T cell therapies have been approved by FDA to treat relapsed or refractory hematological malignancies. However, the...

    Chieh Yang, John Nguyen, Yun Yen in Journal of Biomedical Science
    Article Open access 21 October 2023
  7. Influence of Splenomegaly and Splenectomy on the Immune Cell Profile of Patients with Common Variable Immunodeficiency Disease

    Purpose

    About 25% of patients with common variable immunodeficiency disease (CVID) have splenomegaly, necessitating sometimes splenectomy whom...

    Jean-François Viallard, Marie Parrens, ... Claire Fieschi in Journal of Clinical Immunology
    Article 17 January 2024
  8. Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study

    Purpose

    DiGeorge syndrome has substantial heterogeneity with variable immune deficiency and dysregulation. Implicated immunopathology includes reduced...

    Deepti R. Deshpande, Yesim Y. Demirdag, ... Jordan S. Orange in Journal of Clinical Immunology
    Article 19 September 2020
  9. In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management

    Exposure to immunosuppressive medication in utero is an important cause of secondary T cell lymphopenia in infancy, which can be detected via T cell...

    Hallie A. Carol, Elisa N. Ochfeld, Aisha Ahmed in Immunologic Research
    Article 03 June 2022
  10. A Novel STK4 Mutation Impairs T Cell Immunity Through Dysregulation of Cytokine-Induced Adhesion and Chemotaxis Genes

    Purpose

    Human serine/threonine kinase 4 (STK4) deficiency is a rare, autosomal recessive genetic disorder leading to combined immunodeficiency;...

    Andrea Guennoun, Salim Bougarn, ... Nico Marr in Journal of Clinical Immunology
    Article Open access 24 August 2021
  11. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity

    Alemtuzumab is used with reduced-toxicity conditioning (RTC) in allogeneic hematopoietic cell transplantation (HCT), demonstrating efficacy and...

    Satoshi Miyamoto, Daiki Niizato, ... Hirokazu Kanegane in Journal of Clinical Immunology
    Article 22 May 2024
  12. Severe Combined Immunodeficiency (SCID) Screening in Arizona: Lessons Learned from the First 2 Years

    Purpose

    The incidence of severe combined immunodeficiency (SCID) in the USA was reported as 1 in 58,000 live births. In Arizona, it was anticipated...

    Natalie A. Booth, Catherine M. Freeman, ... Holly Miller in Journal of Clinical Immunology
    Article 22 June 2022
  13. T cell regeneration after immunological injury

    Following periods of haematopoietic cell stress, such as after chemotherapy, radiotherapy, infection and transplantation, patient outcomes are linked...

    Enrico Velardi, Jennifer J. Tsai, Marcel R. M. van den Brink in Nature Reviews Immunology
    Article 23 October 2020
  14. Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis

    Purpose

    Major histocompatibility complex (MHC) class II deficiency is one of the combined immune deficiency disorders caused by defects in the MHC...

    Fayhan J. Alroqi, Musaab A. Alhezam, ... Abdulrahman Alrasheed in Journal of Clinical Immunology
    Article Open access 01 March 2024
  15. Monogenic inborn errors of immunity in autoimmune disorders

    To estimate the prevalence of monogenic inborn errors of immunity in patients with autoimmune diseases (AID), the study included 56 subjects...

    Iyengar Vaishnavi Venkatachari, Akshaya Chougule, ... Mukesh Desai in Immunologic Research
    Article 18 May 2023
  16. Precise identification of cell states altered in disease using healthy single-cell references

    Joint analysis of single-cell genomics data from diseased tissues and a healthy reference can reveal altered cell states. We investigate whether...

    Emma Dann, Ana-Maria Cujba, ... John C. Marioni in Nature Genetics
    Article Open access 12 October 2023
  17. Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)

    Backgr ound

    T-cell receptor excision circle (TREC)-based newborn screening (NBS) for severe combined immunodeficiencies (SCID) was introduced in...

    Carsten Speckmann, Uta Nennstiel, ... Fabian Hauck in Journal of Clinical Immunology
    Article Open access 27 February 2023
  18. The Autoimmune Manifestations in Patients with Genetic Defects in the B Cell Development and Differentiation Stages

    Purpose

    Primary B cell defects manifesting as predominantly antibody deficiencies result from variable inborn errors of the B cell lineage and their...

    Gholamreza Azizi, Mina Fattah Hesari, ... Hassan Abolhassani in Journal of Clinical Immunology
    Article Open access 15 February 2023
  19. Newborn Screening for Severe Combined Immunodeficiency: 10-Year Experience at a Single Referral Center (2009–2018)

    In 2008, newborn screening (NBS) for severe combined immunodeficiency (SCID) began as a pilot study in Wisconsin and has recently been added to every...

    Julia Thorsen, Kayla Kolbert, ... Christine M. Seroogy in Journal of Clinical Immunology
    Article 07 January 2021
Did you find what you were looking for? Share feedback.